| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | LRP1 VLDLR ASTN2 PLCB2 PLCB4 ADAMTS13 FBN1 MEGF6 LRP1B NOTCH4 LRP8 GAS6 | 3.89e-09 | 749 | 36 | 12 | GO:0005509 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.59e-08 | 16 | 36 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 5.21e-08 | 21 | 36 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 5.94e-08 | 200 | 36 | 7 | GO:0008237 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 6.98e-08 | 120 | 36 | 6 | GO:0004222 | |
| GeneOntologyMolecularFunction | integrin binding | 6.51e-07 | 175 | 36 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | reelin receptor activity | 3.16e-06 | 2 | 36 | 2 | GO:0038025 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 6.01e-06 | 20 | 36 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.62e-05 | 85 | 36 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor activity | 1.89e-05 | 4 | 36 | 2 | GO:0030229 | |
| GeneOntologyMolecularFunction | phospholipase activity | 5.15e-05 | 114 | 36 | 4 | GO:0004620 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 8.26e-05 | 599 | 36 | 7 | GO:0050839 | |
| GeneOntologyMolecularFunction | lipase activity | 1.08e-04 | 138 | 36 | 4 | GO:0016298 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.08e-04 | 430 | 36 | 6 | GO:0004175 | |
| GeneOntologyMolecularFunction | peptidase activity | 1.43e-04 | 654 | 36 | 7 | GO:0008233 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.68e-04 | 323 | 36 | 5 | GO:1901681 | |
| GeneOntologyMolecularFunction | heparin binding | 3.84e-04 | 192 | 36 | 4 | GO:0008201 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase inhibitor activity involved in apoptotic process | 8.51e-04 | 24 | 36 | 2 | GO:0043027 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 9.99e-04 | 26 | 36 | 2 | GO:0004435 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 1.24e-03 | 29 | 36 | 2 | GO:0004629 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.33e-03 | 268 | 36 | 4 | GO:0005539 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 1.81e-03 | 35 | 36 | 2 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 1.81e-03 | 35 | 36 | 2 | GO:0071814 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 3.81e-03 | 51 | 36 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase regulator activity involved in apoptotic process | 4.26e-03 | 54 | 36 | 2 | GO:0043028 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.67e-03 | 188 | 36 | 3 | GO:0005201 | |
| GeneOntologyBiologicalProcess | cellular response to interferon-alpha | 2.38e-06 | 15 | 37 | 3 | GO:0035457 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 2.71e-06 | 124 | 37 | 5 | GO:0007229 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 4.14e-06 | 377 | 37 | 7 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 4.21e-06 | 378 | 37 | 7 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 4.28e-06 | 379 | 37 | 7 | GO:0045229 | |
| GeneOntologyBiologicalProcess | response to interferon-alpha | 1.34e-05 | 26 | 37 | 3 | GO:0035455 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 7.67e-05 | 405 | 37 | 6 | GO:0033674 | |
| GeneOntologyBiologicalProcess | reelin-mediated signaling pathway | 8.71e-05 | 8 | 37 | 2 | GO:0038026 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 2.17e-04 | 490 | 37 | 6 | GO:0051347 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 2.27e-04 | 494 | 37 | 6 | GO:0031346 | |
| GeneOntologyBiologicalProcess | cellular response to cytokine stimulus | 2.60e-04 | 967 | 37 | 8 | GO:0071345 | |
| GeneOntologyBiologicalProcess | heart development | 3.43e-04 | 757 | 37 | 7 | GO:0007507 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 3.81e-04 | 350 | 37 | 5 | GO:0045860 | |
| GeneOntologyBiologicalProcess | glial cell migration | 3.97e-04 | 80 | 37 | 3 | GO:0008347 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS17 ADAMTS19 FRAS1 ADAMTS13 FBN1 ADAM11 FN1 MEGF6 ADAMTS1 | 1.58e-06 | 656 | 37 | 9 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS17 ADAMTS19 FRAS1 ADAMTS13 FBN1 ADAM11 FN1 MEGF6 ADAMTS1 | 1.62e-06 | 658 | 37 | 9 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 3.44e-05 | 530 | 37 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | basement membrane | 6.28e-05 | 122 | 37 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | receptor complex | 5.01e-04 | 581 | 37 | 6 | GO:0043235 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.73e-03 | 332 | 37 | 4 | GO:0005788 | |
| GeneOntologyCellularComponent | cell surface | 2.98e-03 | 1111 | 37 | 7 | GO:0009986 | |
| GeneOntologyCellularComponent | synaptic membrane | 3.46e-03 | 583 | 37 | 5 | GO:0097060 | |
| HumanPheno | Hypoplastic superior helix | 4.20e-05 | 4 | 14 | 2 | HP:0008559 | |
| HumanPheno | Iridodonesis | 6.98e-05 | 5 | 14 | 2 | HP:0100693 | |
| MousePheno | cardiac valve regurgitation | 2.73e-05 | 26 | 32 | 3 | MP:0009384 | |
| MousePheno | abnormal heart valve physiology | 4.24e-05 | 30 | 32 | 3 | MP:0011926 | |
| MousePheno | abnormal cerebellum development | 6.48e-05 | 96 | 32 | 4 | MP:0000854 | |
| MousePheno | small cerebellum | 1.49e-04 | 119 | 32 | 4 | MP:0000852 | |
| Domain | EGF_1 | TENM1 LRP1 VLDLR ASTN2 ITGBL1 HHIP FBN1 ADAM11 C7 FN1 MEGF6 ADAM23 LRP1B NOTCH4 LRP8 GAS6 | 9.06e-21 | 255 | 37 | 16 | PS00022 |
| Domain | EGF-like_dom | TENM1 LRP1 VLDLR ITGBL1 HHIP FRAS1 FBN1 ADAM11 C7 MEGF6 ADAM23 LRP1B NOTCH4 LRP8 GAS6 | 3.53e-19 | 249 | 37 | 15 | IPR000742 |
| Domain | EGF_2 | TENM1 LRP1 VLDLR ASTN2 ITGBL1 HHIP FBN1 ADAM11 C7 MEGF6 ADAM23 LRP1B NOTCH4 LRP8 GAS6 | 9.06e-19 | 265 | 37 | 15 | PS01186 |
| Domain | EGF_3 | TENM1 LRP1 VLDLR ASTN2 HHIP FBN1 ADAM11 C7 MEGF6 ADAM23 LRP1B NOTCH4 LRP8 GAS6 | 7.98e-18 | 235 | 37 | 14 | PS50026 |
| Domain | EGF | TENM1 LRP1 VLDLR ITGBL1 HHIP FRAS1 FBN1 ADAM11 MEGF6 ADAM23 LRP1B NOTCH4 LRP8 GAS6 | 7.98e-18 | 235 | 37 | 14 | SM00181 |
| Domain | EGF-like_CS | TENM1 LRP1 VLDLR HHIP FBN1 ADAM11 C7 FN1 MEGF6 ADAM23 LRP1B NOTCH4 LRP8 GAS6 | 3.50e-17 | 261 | 37 | 14 | IPR013032 |
| Domain | Growth_fac_rcpt_ | 3.55e-13 | 156 | 37 | 10 | IPR009030 | |
| Domain | EGF_CA | 5.02e-12 | 86 | 37 | 8 | PF07645 | |
| Domain | ADAM_Cys-rich | 1.13e-11 | 27 | 37 | 6 | IPR006586 | |
| Domain | ACR | 1.13e-11 | 27 | 37 | 6 | SM00608 | |
| Domain | EGF_Ca-bd_CS | 1.35e-11 | 97 | 37 | 8 | IPR018097 | |
| Domain | EGF_CA | 1.59e-11 | 99 | 37 | 8 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.73e-11 | 100 | 37 | 8 | PS00010 | |
| Domain | EGF_extracell | 2.35e-11 | 60 | 37 | 7 | IPR013111 | |
| Domain | EGF_2 | 2.35e-11 | 60 | 37 | 7 | PF07974 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.77e-11 | 106 | 37 | 8 | IPR000152 | |
| Domain | EGF_CA | 8.66e-11 | 122 | 37 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 9.87e-11 | 124 | 37 | 8 | IPR001881 | |
| Domain | - | 1.23e-10 | 39 | 37 | 6 | 2.120.10.30 | |
| Domain | DISINTEGRIN_1 | 1.44e-10 | 40 | 37 | 6 | PS00427 | |
| Domain | ADAM_MEPRO | 1.44e-10 | 40 | 37 | 6 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.44e-10 | 40 | 37 | 6 | PS50214 | |
| Domain | Reprolysin | 1.44e-10 | 40 | 37 | 6 | PF01421 | |
| Domain | Peptidase_M12B | 1.44e-10 | 40 | 37 | 6 | IPR001590 | |
| Domain | Disintegrin_dom | 1.69e-10 | 41 | 37 | 6 | IPR001762 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.49e-10 | 46 | 37 | 6 | IPR011042 | |
| Domain | EGF | 4.68e-09 | 126 | 37 | 7 | PF00008 | |
| Domain | MetalloPept_cat_dom | 1.15e-08 | 81 | 37 | 6 | IPR024079 | |
| Domain | - | 1.15e-08 | 81 | 37 | 6 | 3.40.390.10 | |
| Domain | Peptidase_M12B_N | 1.26e-08 | 39 | 37 | 5 | IPR002870 | |
| Domain | Pep_M12B_propep | 1.26e-08 | 39 | 37 | 5 | PF01562 | |
| Domain | Ldl_recept_b | 1.29e-08 | 14 | 37 | 4 | PF00058 | |
| Domain | LDLRB | 1.29e-08 | 14 | 37 | 4 | PS51120 | |
| Domain | LDLR_class-A_CS | 1.44e-08 | 40 | 37 | 5 | IPR023415 | |
| Domain | LY | 1.75e-08 | 15 | 37 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.75e-08 | 15 | 37 | 4 | IPR000033 | |
| Domain | Ldl_recept_a | 2.66e-08 | 45 | 37 | 5 | PF00057 | |
| Domain | - | 2.98e-08 | 46 | 37 | 5 | 4.10.400.10 | |
| Domain | LDLRA_1 | 3.71e-08 | 48 | 37 | 5 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 4.12e-08 | 49 | 37 | 5 | IPR002172 | |
| Domain | LDLa | 4.12e-08 | 49 | 37 | 5 | SM00192 | |
| Domain | LDLRA_2 | 4.12e-08 | 49 | 37 | 5 | PS50068 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.35e-07 | 24 | 37 | 4 | IPR013273 | |
| Domain | TSP_1 | 1.49e-07 | 63 | 37 | 5 | PF00090 | |
| Domain | TSP1 | 1.75e-07 | 65 | 37 | 5 | SM00209 | |
| Domain | TSP1_rpt | 1.75e-07 | 65 | 37 | 5 | IPR000884 | |
| Domain | TSP1 | 1.75e-07 | 65 | 37 | 5 | PS50092 | |
| Domain | cEGF | 1.89e-07 | 26 | 37 | 4 | IPR026823 | |
| Domain | cEGF | 1.89e-07 | 26 | 37 | 4 | PF12662 | |
| Domain | ZINC_PROTEASE | 1.37e-06 | 98 | 37 | 5 | PS00142 | |
| Domain | DUF5050 | 3.82e-06 | 2 | 37 | 2 | IPR032485 | |
| Domain | DUF5050 | 3.82e-06 | 2 | 37 | 2 | PF16472 | |
| Domain | ADAM_spacer1 | 1.23e-05 | 23 | 37 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.23e-05 | 23 | 37 | 3 | PF05986 | |
| Domain | hEGF | 2.27e-05 | 28 | 37 | 3 | PF12661 | |
| Domain | PLC-beta | 2.29e-05 | 4 | 37 | 2 | IPR016280 | |
| Domain | Pept_M10_metallopeptidase | 8.36e-05 | 43 | 37 | 3 | IPR001818 | |
| Domain | MACPF | 2.08e-04 | 11 | 37 | 2 | PF01823 | |
| Domain | MACPF | 2.49e-04 | 12 | 37 | 2 | SM00457 | |
| Domain | MACPF | 2.49e-04 | 12 | 37 | 2 | IPR020864 | |
| Domain | Quinoprot_gluc/sorb_DH | 2.49e-04 | 12 | 37 | 2 | IPR011041 | |
| Domain | PLAC | 3.42e-04 | 14 | 37 | 2 | PF08686 | |
| Domain | PIPLC_Y_DOMAIN | 3.95e-04 | 15 | 37 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 3.95e-04 | 15 | 37 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 3.95e-04 | 15 | 37 | 2 | IPR015359 | |
| Domain | PI-PLC-Y | 3.95e-04 | 15 | 37 | 2 | PF00387 | |
| Domain | PLipase_C_Pinositol-sp_Y | 3.95e-04 | 15 | 37 | 2 | IPR001711 | |
| Domain | EF-hand_like | 3.95e-04 | 15 | 37 | 2 | PF09279 | |
| Domain | PLCYc | 3.95e-04 | 15 | 37 | 2 | SM00149 | |
| Domain | Furin_repeat | 5.73e-04 | 18 | 37 | 2 | IPR006212 | |
| Domain | PI-PLC-X | 5.73e-04 | 18 | 37 | 2 | PF00388 | |
| Domain | ADAM_CR | 5.73e-04 | 18 | 37 | 2 | PF08516 | |
| Domain | PLCXc | 5.73e-04 | 18 | 37 | 2 | SM00148 | |
| Domain | FU | 5.73e-04 | 18 | 37 | 2 | SM00261 | |
| Domain | PIPLC_X_DOMAIN | 6.39e-04 | 19 | 37 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 6.39e-04 | 19 | 37 | 2 | IPR000909 | |
| Domain | PLAC | 6.39e-04 | 19 | 37 | 2 | IPR010909 | |
| Domain | PLAC | 6.39e-04 | 19 | 37 | 2 | PS50900 | |
| Domain | - | 7.09e-04 | 20 | 37 | 2 | 4.10.70.10 | |
| Domain | DISIN | 7.83e-04 | 21 | 37 | 2 | SM00050 | |
| Domain | Disintegrin | 7.83e-04 | 21 | 37 | 2 | PF00200 | |
| Domain | - | 1.11e-03 | 25 | 37 | 2 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 1.11e-03 | 25 | 37 | 2 | IPR017946 | |
| Domain | CYSTEINE_SWITCH | 2.98e-03 | 41 | 37 | 2 | PS00546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.44e-07 | 68 | 29 | 5 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.13e-06 | 39 | 29 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.13e-06 | 39 | 29 | 4 | MM15165 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 9.77e-06 | 143 | 29 | 5 | M27275 | |
| Pathway | WP_CANCER_PATHWAYS | 5.85e-05 | 507 | 29 | 7 | M48302 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 6.10e-05 | 6 | 29 | 2 | M47548 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 6.92e-05 | 109 | 29 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.43e-05 | 111 | 29 | 4 | M27416 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 8.51e-05 | 42 | 29 | 3 | M174 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 8.53e-05 | 7 | 29 | 2 | MM1566 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 8.53e-05 | 7 | 29 | 2 | M22049 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY | 8.53e-05 | 7 | 29 | 2 | M47505 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 1.01e-04 | 120 | 29 | 4 | MM14982 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.41e-04 | 250 | 29 | 5 | M27554 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY | 1.82e-04 | 10 | 29 | 2 | M47644 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.82e-04 | 10 | 29 | 2 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.22e-04 | 11 | 29 | 2 | M49033 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY | 2.22e-04 | 11 | 29 | 2 | M47637 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY | 2.66e-04 | 12 | 29 | 2 | M47649 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY | 2.66e-04 | 12 | 29 | 2 | M47628 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 3.14e-04 | 13 | 29 | 2 | M47656 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 3.14e-04 | 13 | 29 | 2 | M42551 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 3.66e-04 | 14 | 29 | 2 | MM15277 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 3.66e-04 | 14 | 29 | 2 | M27564 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 4.60e-04 | 74 | 29 | 3 | MM15962 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 5.45e-04 | 17 | 29 | 2 | M212 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 6.13e-04 | 18 | 29 | 2 | M47659 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 6.84e-04 | 19 | 29 | 2 | M47596 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 6.84e-04 | 19 | 29 | 2 | M47543 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 6.84e-04 | 19 | 29 | 2 | MM15512 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 7.59e-04 | 20 | 29 | 2 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 8.38e-04 | 21 | 29 | 2 | M47689 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY | 8.38e-04 | 21 | 29 | 2 | M47638 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 8.38e-04 | 21 | 29 | 2 | M47542 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 9.20e-04 | 22 | 29 | 2 | M39795 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 9.20e-04 | 22 | 29 | 2 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 9.20e-04 | 22 | 29 | 2 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.01e-03 | 23 | 29 | 2 | M47676 | |
| Pathway | KEGG_MELANOGENESIS | 1.14e-03 | 101 | 29 | 3 | M7761 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY | 1.29e-03 | 26 | 29 | 2 | M47557 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.29e-03 | 26 | 29 | 2 | M27053 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS17 ADAMTS19 BIRC3 ADAMTS13 FBN1 FN1 MEGF6 ADAMTS1 GAS6 | 1.38e-03 | 1389 | 29 | 9 | MM15307 |
| Pathway | WP_COMPREHENSIVE_IL17A_SIGNALING | 1.46e-03 | 110 | 29 | 3 | MM16642 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.49e-03 | 28 | 29 | 2 | MM14711 | |
| Pathway | PID_LIS1_PATHWAY | 1.49e-03 | 28 | 29 | 2 | M163 | |
| Pathway | PID_REELIN_PATHWAY | 1.49e-03 | 28 | 29 | 2 | M69 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.49e-03 | 28 | 29 | 2 | M47508 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 1.57e-03 | 113 | 29 | 3 | M39669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.60e-03 | 29 | 29 | 2 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.60e-03 | 29 | 29 | 2 | M47377 | |
| Pathway | WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS | 1.72e-03 | 30 | 29 | 2 | M42578 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.72e-03 | 30 | 29 | 2 | MM15517 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 1.83e-03 | 31 | 29 | 2 | M47554 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.89e-03 | 261 | 29 | 4 | M42565 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.95e-03 | 32 | 29 | 2 | MM14854 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 2.05e-03 | 124 | 29 | 3 | M27285 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 2.07e-03 | 33 | 29 | 2 | M39745 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.60e-03 | 37 | 29 | 2 | M27134 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 2.89e-03 | 39 | 29 | 2 | M39905 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.89e-03 | 39 | 29 | 2 | MM14496 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.89e-03 | 39 | 29 | 2 | MM14601 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.90e-03 | 140 | 29 | 3 | M587 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 3.50e-03 | 43 | 29 | 2 | M53 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 3.59e-03 | 151 | 29 | 3 | M19428 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.66e-03 | 44 | 29 | 2 | M26969 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 3.83e-03 | 45 | 29 | 2 | MM15344 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 4.00e-03 | 46 | 29 | 2 | M48317 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 4.18e-03 | 325 | 29 | 4 | M12868 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | 4.22e-03 | 326 | 29 | 4 | M39379 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 4.30e-03 | 161 | 29 | 3 | M39770 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 4.35e-03 | 48 | 29 | 2 | M27642 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 4.35e-03 | 48 | 29 | 2 | MM14589 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 4.35e-03 | 48 | 29 | 2 | M26964 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 4.53e-03 | 49 | 29 | 2 | M40046 | |
| Pathway | KEGG_ALZHEIMERS_DISEASE | 4.68e-03 | 166 | 29 | 3 | M16024 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 4.71e-03 | 50 | 29 | 2 | M47951 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 5.47e-03 | 54 | 29 | 2 | M3896 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 5.47e-03 | 54 | 29 | 2 | M26911 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 5.67e-03 | 55 | 29 | 2 | M17807 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 5.68e-03 | 178 | 29 | 3 | M2890 | |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | 5.87e-03 | 56 | 29 | 2 | M1053 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 6.08e-03 | 57 | 29 | 2 | M48326 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 3.67e-09 | 18 | 38 | 4 | 35503090 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 7.15e-09 | 21 | 38 | 4 | 21337463 | |
| Pubmed | 4.20e-08 | 7 | 38 | 3 | 11867212 | ||
| Pubmed | 4.20e-08 | 7 | 38 | 3 | 12169628 | ||
| Pubmed | 6.71e-08 | 8 | 38 | 3 | 10380922 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 8.69e-08 | 101 | 38 | 5 | 23382219 | |
| Pubmed | 1.01e-07 | 9 | 38 | 3 | 20005821 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 2.63e-07 | 12 | 38 | 3 | 25770910 | |
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 4.34e-07 | 14 | 38 | 3 | 17389516 | |
| Pubmed | 4.34e-07 | 14 | 38 | 3 | 15082773 | ||
| Pubmed | 9.71e-07 | 18 | 38 | 3 | 10827173 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 22589727 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 33454014 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 19037100 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 1.16e-06 | 2 | 38 | 2 | 15963947 | |
| Pubmed | Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. | 1.16e-06 | 2 | 38 | 2 | 12871934 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 18301736 | ||
| Pubmed | The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice. | 1.16e-06 | 2 | 38 | 2 | 17261317 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 36446235 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 22782528 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 11867643 | ||
| Pubmed | Identification and validation of Ifit1 as an important innate immune bottleneck. | 1.16e-06 | 2 | 38 | 2 | 22745654 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 23824812 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 21601501 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 27823966 | ||
| Pubmed | A viral RNA structural element alters host recognition of nonself RNA. | 1.16e-06 | 2 | 38 | 2 | 24482115 | |
| Pubmed | Fibrillin-1 microfibril deposition is dependent on fibronectin assembly. | 1.16e-06 | 2 | 38 | 2 | 18653538 | |
| Pubmed | Clearance of coagulation factor VIII in very low-density lipoprotein receptor knockout mice. | 1.16e-06 | 2 | 38 | 2 | 15327526 | |
| Pubmed | LRP1 is required for novobiocin-mediated fibronectin turnover. | 1.16e-06 | 2 | 38 | 2 | 30061663 | |
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 1.16e-06 | 2 | 38 | 2 | 24484584 | |
| Pubmed | Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA. | 1.16e-06 | 2 | 38 | 2 | 24098121 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 27240734 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 31726086 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 25927359 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 30282041 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 34929721 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 26157117 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 30873003 | ||
| Pubmed | Complex contributions of fibronectin to initiation and maturation of microfibrils. | 1.16e-06 | 2 | 38 | 2 | 24070235 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 26459629 | ||
| Pubmed | 1.39e-06 | 75 | 38 | 4 | 20637190 | ||
| Pubmed | 1.83e-06 | 22 | 38 | 3 | 15733672 | ||
| Pubmed | 3.46e-06 | 27 | 38 | 3 | 35894043 | ||
| Pubmed | Reelin together with ApoER2 regulates interneuron migration in the olfactory bulb. | 3.48e-06 | 3 | 38 | 2 | 23209795 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 9693107 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 20427281 | ||
| Pubmed | Functional importance of covalent homodimer of reelin protein linked via its central region. | 3.48e-06 | 3 | 38 | 2 | 21844191 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 18277139 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 7896268 | ||
| Pubmed | Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo. | 3.48e-06 | 3 | 38 | 2 | 24251389 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 15950758 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 23083738 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 18778775 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 30232164 | ||
| Pubmed | Contributions of VLDLR and LRP8 in the establishment of retinogeniculate projections. | 3.48e-06 | 3 | 38 | 2 | 23758727 | |
| Pubmed | Mouse p56 blocks a distinct function of eukaryotic initiation factor 3 in translation initiation. | 3.48e-06 | 3 | 38 | 2 | 15561726 | |
| Pubmed | ApoER2 function in the establishment and maintenance of retinal synaptic connectivity. | 3.48e-06 | 3 | 38 | 2 | 21976526 | |
| Pubmed | Reelin and its receptors, VLDLR and ApoER2, in melanocytic nevi. | 3.48e-06 | 3 | 38 | 2 | 28255385 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 18367731 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 11931574 | ||
| Pubmed | Novel characteristics of the function and induction of murine p56 family proteins. | 3.48e-06 | 3 | 38 | 2 | 18768971 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 35034537 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 19856081 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 28123028 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 11920707 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 18039658 | ||
| Pubmed | Binding of purified Reelin to ApoER2 and VLDLR mediates tyrosine phosphorylation of Disabled-1. | 3.48e-06 | 3 | 38 | 2 | 12670700 | |
| Pubmed | Molecular structure and interaction of recombinant human type XVI collagen. | 3.48e-06 | 3 | 38 | 2 | 15165854 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 12807892 | ||
| Pubmed | The Reelin receptors ApoER2 and VLDLR are direct target genes of HIC1 (Hypermethylated In Cancer 1). | 3.48e-06 | 3 | 38 | 2 | 24076391 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 22170052 | ||
| Pubmed | Semaphorin 3E/PlexinD1 signaling is required for cardiac ventricular compaction. | 5.84e-06 | 32 | 38 | 3 | 31434798 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 16481437 | ||
| Pubmed | Disabled1 regulates the intracellular trafficking of reelin receptors. | 6.96e-06 | 4 | 38 | 2 | 15718228 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 23506116 | ||
| Pubmed | Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. | 6.96e-06 | 4 | 38 | 2 | 12167620 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 9753089 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 24991014 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 14724251 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 8006086 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 17548821 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 24198415 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 6.96e-06 | 4 | 38 | 2 | 25034023 | |
| Pubmed | Phospholipase C-β1 potentiates glucose-stimulated insulin secretion. | 6.96e-06 | 4 | 38 | 2 | 31268747 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 24381170 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 24478444 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 17079283 | ||
| Pubmed | Structural basis for specific recognition of reelin by its receptors. | 6.96e-06 | 4 | 38 | 2 | 20223215 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 20301293 | ||
| Pubmed | Reelin-Nrp1 Interaction Regulates Neocortical Dendrite Development in a Context-Specific Manner. | 6.96e-06 | 4 | 38 | 2 | 33009002 | |
| Pubmed | Interferon-induced Ifit proteins: their role in viral pathogenesis. | 6.96e-06 | 4 | 38 | 2 | 25428874 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 17442808 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 8660659 | ||
| Pubmed | Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice. | 6.96e-06 | 4 | 38 | 2 | 17553874 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 10571240 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 10571241 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 12687696 | ||
| Pubmed | Sendai virus pathogenesis in mice is prevented by Ifit2 and exacerbated by interferon. | 6.96e-06 | 4 | 38 | 2 | 25231314 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 15863833 | ||
| Pubmed | Expression and regulation of reelin and its receptors in the enteric nervous system. | 6.96e-06 | 4 | 38 | 2 | 24844606 | |
| Interaction | ZFP41 interactions | 3.54e-06 | 57 | 37 | 4 | int:ZFP41 | |
| Interaction | DYRK1A interactions | 5.77e-06 | 552 | 37 | 8 | int:DYRK1A | |
| Interaction | ADAMTS17 interactions | 7.41e-06 | 21 | 37 | 3 | int:ADAMTS17 | |
| Interaction | FBXO2 interactions | 8.46e-06 | 411 | 37 | 7 | int:FBXO2 | |
| Interaction | IGFL3 interactions | 1.06e-05 | 75 | 37 | 4 | int:IGFL3 | |
| Interaction | NTN5 interactions | 1.12e-05 | 24 | 37 | 3 | int:NTN5 | |
| Interaction | B3GLCT interactions | 3.90e-05 | 36 | 37 | 3 | int:B3GLCT | |
| Interaction | DAB1 interactions | 4.33e-05 | 107 | 37 | 4 | int:DAB1 | |
| Interaction | C2CD4B interactions | 7.16e-05 | 44 | 37 | 3 | int:C2CD4B | |
| Interaction | CLU interactions | 8.09e-05 | 245 | 37 | 5 | int:CLU | |
| Interaction | IFIT1B interactions | 9.12e-05 | 8 | 37 | 2 | int:IFIT1B | |
| Interaction | ZNF408 interactions | 1.41e-04 | 145 | 37 | 4 | int:ZNF408 | |
| Interaction | ANKRD36B interactions | 1.81e-04 | 60 | 37 | 3 | int:ANKRD36B | |
| Interaction | PLAT interactions | 2.10e-04 | 63 | 37 | 3 | int:PLAT | |
| Interaction | HRG interactions | 2.10e-04 | 63 | 37 | 3 | int:HRG | |
| Cytoband | 10q23.31 | 3.68e-04 | 34 | 38 | 2 | 10q23.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p12 | 1.26e-03 | 63 | 38 | 2 | chr7p12 | |
| Cytoband | 12q13 | 1.60e-03 | 71 | 38 | 2 | 12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 5.15e-03 | 129 | 38 | 2 | chr2q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 5.16e-03 | 423 | 38 | 3 | chr12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q23 | 1.14e-02 | 195 | 38 | 2 | chr10q23 | |
| GeneFamily | Low density lipoprotein receptors | 3.26e-09 | 13 | 28 | 4 | 634 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.75e-08 | 19 | 28 | 4 | 50 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 3.89e-04 | 19 | 28 | 2 | 832 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 7.93e-04 | 27 | 28 | 2 | 47 | |
| GeneFamily | Phospholipases | 1.92e-03 | 42 | 28 | 2 | 467 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.36e-02 | 115 | 28 | 2 | 769 | |
| GeneFamily | Fibronectin type III domain containing | 2.53e-02 | 160 | 28 | 2 | 555 | |
| Coexpression | NABA_MATRISOME | ADAMTS17 ADAMTS19 HHIP FRAS1 ADAMTS13 FBN1 ADAM11 FN1 MEGF6 ADAMTS1 ADAM23 WNT10B GAS6 | 8.26e-10 | 1008 | 38 | 13 | MM17056 |
| Coexpression | NABA_MATRISOME | ADAMTS17 ADAMTS19 HHIP FRAS1 ADAMTS13 FBN1 ADAM11 FN1 MEGF6 ADAMTS1 ADAM23 WNT10B GAS6 | 1.02e-09 | 1026 | 38 | 13 | M5889 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS17 ADAMTS19 HHIP ADAMTS13 ADAM11 MEGF6 ADAMTS1 ADAM23 WNT10B | 8.31e-07 | 738 | 38 | 9 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS17 ADAMTS19 HHIP ADAMTS13 ADAM11 MEGF6 ADAMTS1 ADAM23 WNT10B | 9.60e-07 | 751 | 38 | 9 | M5885 |
| Coexpression | NABA_ECM_REGULATORS | 1.14e-06 | 238 | 38 | 6 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 1.26e-06 | 242 | 38 | 6 | MM17062 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.95e-06 | 261 | 38 | 6 | M1834 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 1.23e-05 | 31 | 38 | 3 | M1291 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 2.11e-05 | 37 | 38 | 3 | MM1121 | |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_UP | 2.16e-05 | 398 | 38 | 6 | M4872 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 3.79e-05 | 440 | 38 | 6 | M39039 | |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP | 4.91e-05 | 461 | 38 | 6 | M14127 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 5.26e-05 | 50 | 38 | 3 | M1259 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 5.92e-05 | 52 | 38 | 3 | MM1118 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.10e-04 | 64 | 38 | 3 | M2572 | |
| Coexpression | HASEGAWA_TUMORIGENESIS_BY_RET_C634R | 1.12e-04 | 11 | 38 | 2 | MM554 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 1.15e-04 | 65 | 38 | 3 | M39309 | |
| Coexpression | GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP | 1.53e-04 | 187 | 38 | 4 | M7123 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.66e-04 | 191 | 38 | 4 | MM17059 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.76e-04 | 194 | 38 | 4 | M39122 | |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.77e-04 | 75 | 38 | 3 | MM1143 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.83e-04 | 196 | 38 | 4 | M3008 | |
| Coexpression | GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN | 1.94e-04 | 199 | 38 | 4 | M6605 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP | 1.94e-04 | 199 | 38 | 4 | M7420 | |
| Coexpression | GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN | 1.98e-04 | 200 | 38 | 4 | M8654 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 2.43e-04 | 211 | 38 | 4 | M12225 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 2.43e-04 | 211 | 38 | 4 | MM17081 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN | 2.75e-04 | 17 | 38 | 2 | MM1225 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN | 2.75e-04 | 17 | 38 | 2 | M1767 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN | 2.90e-04 | 407 | 38 | 5 | M19541 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 3.13e-04 | 91 | 38 | 3 | M40180 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 3.32e-04 | 229 | 38 | 4 | MM16607 | |
| Coexpression | SENESE_HDAC1_AND_HDAC2_TARGETS_UP | 4.15e-04 | 243 | 38 | 4 | M18938 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C2 | 4.22e-04 | 21 | 38 | 2 | M4767 | |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_A | 4.76e-04 | 105 | 38 | 3 | M14228 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 7.99e-07 | 97 | 38 | 5 | GSM777046_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.46e-06 | 65 | 38 | 4 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | 7.12e-06 | 778 | 38 | 9 | gudmap_kidney_adult_RenalCapsule_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.08e-05 | 437 | 38 | 7 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.22e-05 | 445 | 38 | 7 | GSM777043_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 1.38e-05 | 82 | 38 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.60e-05 | 464 | 38 | 7 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.74e-05 | 87 | 38 | 4 | GSM777050_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.75e-05 | 182 | 38 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 3.74e-05 | 356 | 38 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.56e-05 | 369 | 38 | 6 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | 5.51e-05 | 773 | 38 | 8 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 5.72e-05 | 777 | 38 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 7.96e-05 | 408 | 38 | 6 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45-EpCAm+Ly51-MHCIIhi, Thymus, avg-1 | 8.28e-05 | 411 | 38 | 6 | GSM854302_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 8.43e-05 | 130 | 38 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 1.32e-04 | 146 | 38 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.41e-04 | 453 | 38 | 6 | GSM777067_500 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | 1.64e-04 | 904 | 38 | 8 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.65e-04 | 466 | 38 | 6 | GSM777050_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_500 | 2.23e-04 | 493 | 38 | 6 | PCBC_ctl_CardiacMyocyte_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500 | 2.26e-04 | 494 | 38 | 6 | JC_fibro_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | 3.05e-04 | 990 | 38 | 8 | JC_fibro_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 4.16e-04 | 357 | 38 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 4.72e-04 | 85 | 38 | 3 | GSM777067_100 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500_k-means-cluster#3 | 4.90e-04 | 206 | 38 | 4 | JC_fibro_500_K3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 5.07e-04 | 373 | 38 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.29e-04 | 814 | 38 | 7 | JC_fibro_2500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | 5.45e-04 | 818 | 38 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 | |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45- EpCAm+ Ly51- MHCIIhi, Thymus, avg-2 | 5.79e-04 | 384 | 38 | 5 | GSM777041_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 6.33e-04 | 94 | 38 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_500 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 | 6.47e-04 | 842 | 38 | 7 | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.91e-04 | 234 | 38 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500 | 8.69e-04 | 240 | 38 | 4 | gudmap_kidney_adult_RenalCapsule_k1_500 | |
| CoexpressionAtlas | thyroid gland | 8.69e-04 | 240 | 38 | 4 | thyroid gland | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lu, CD11chi CD11b low CD103+ MHCII+ SiglecF-, Lung, avg-3 | 9.04e-04 | 424 | 38 | 5 | GSM538231_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_500 | 9.04e-04 | 424 | 38 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#3_top-relative-expression-ranked_200 | 1.00e-03 | 110 | 38 | 3 | gudmap_kidney_adult_RenalCapsule_k3_200 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 1.18e-03 | 450 | 38 | 5 | GSM777063_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.24e-03 | 455 | 38 | 5 | GSM777055_500 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.26e-11 | 163 | 38 | 7 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-10 | 176 | 38 | 7 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-10 | 176 | 38 | 7 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.25e-10 | 188 | 38 | 7 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.33e-10 | 189 | 38 | 7 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.42e-10 | 190 | 38 | 7 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.90e-10 | 195 | 38 | 7 | 1c1135be421af98cd0077bec1ff2c4158d42aa21 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.90e-10 | 195 | 38 | 7 | 11d421bbbb71425d59cbdd673e052e00d5f0a768 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.90e-10 | 195 | 38 | 7 | 1f005ee1da66b539bd200aaa98f46edbbc7f12e4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.90e-10 | 195 | 38 | 7 | 10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.47e-10 | 200 | 38 | 7 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.65e-09 | 170 | 38 | 6 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-08 | 184 | 38 | 6 | 4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-08 | 185 | 38 | 6 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-08 | 185 | 38 | 6 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-08 | 186 | 38 | 6 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.18e-08 | 187 | 38 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-08 | 190 | 38 | 6 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | Endothelial-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.33e-08 | 191 | 38 | 6 | f702dfe88a9b04091dae87df61b2b4f43525f86a | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.33e-08 | 191 | 38 | 6 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-08 | 192 | 38 | 6 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-08 | 192 | 38 | 6 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-08 | 194 | 38 | 6 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-08 | 194 | 38 | 6 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-08 | 194 | 38 | 6 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.51e-08 | 195 | 38 | 6 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.51e-08 | 195 | 38 | 6 | 6bb6349d6ec8da094fe1c7c590021989337aeb0b | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.51e-08 | 195 | 38 | 6 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.51e-08 | 195 | 38 | 6 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-08 | 195 | 38 | 6 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.51e-08 | 195 | 38 | 6 | a3b468125e48f072255cede7645f6692298ecf54 | |
| ToppCell | P03-Mesenchymal|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.51e-08 | 195 | 38 | 6 | 6180309c6ae278b996fd98c57461cbc129c028ba | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.51e-08 | 195 | 38 | 6 | 2f9a274b26fc528a85f50933ec2f4db1dc9da0ca | |
| ToppCell | E17.5-Mesenchymal|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.56e-08 | 196 | 38 | 6 | b4ee991445b612506372b9361ebfe72cb59b811e | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-08 | 196 | 38 | 6 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.60e-08 | 197 | 38 | 6 | 06a0d7062dadda656decaf77dcef9a10b5f2698d | |
| ToppCell | PND01-Mesenchymal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.60e-08 | 197 | 38 | 6 | 292b8cc3dafddf5d323fe4e3d3ea5ac61e6ce027 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-08 | 197 | 38 | 6 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.60e-08 | 197 | 38 | 6 | d35c7a36135b5ed6a7bf2f934849678eba2a0177 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.70e-08 | 199 | 38 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.76e-08 | 200 | 38 | 6 | 376c1a77031e090be96948b47c78ac0d393f5775 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-08 | 200 | 38 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-08 | 200 | 38 | 6 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-08 | 200 | 38 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-08 | 200 | 38 | 6 | f74b9b0e27afedd589e828d30194e8417029817a | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 1.76e-08 | 200 | 38 | 6 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-08 | 200 | 38 | 6 | fd92d8250c6ad1e8bb46b303ac37f8dcf80387d8 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-08 | 200 | 38 | 6 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.76e-07 | 164 | 38 | 5 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 169 | 38 | 5 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 169 | 38 | 5 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 169 | 38 | 5 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | Endothelial-A-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.49e-07 | 172 | 38 | 5 | a3201773a25832e92dd113fad165f1ecd37f5e91 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.59e-07 | 173 | 38 | 5 | b23b408acc29a667cce104429afef1a6cf2720a5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.70e-07 | 174 | 38 | 5 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-07 | 177 | 38 | 5 | b872ee91e01265b101b81bd304cf6b95d5419e68 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.14e-07 | 178 | 38 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-07 | 181 | 38 | 5 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.49e-07 | 181 | 38 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-07 | 181 | 38 | 5 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.62e-07 | 182 | 38 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-07 | 182 | 38 | 5 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-07 | 182 | 38 | 5 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.01e-07 | 185 | 38 | 5 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.14e-07 | 186 | 38 | 5 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.28e-07 | 187 | 38 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Control / Disease state, Lineage and Cell class | 5.42e-07 | 188 | 38 | 5 | f5b7dbc89f992c13280d36a34935be83906b1bc0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.42e-07 | 188 | 38 | 5 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | Fibroblast-A|World / shred on cell class and cell subclass (v4) | 5.42e-07 | 188 | 38 | 5 | 6740bed5fb8f45b6eea17041894b804214c2a4ae | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 5.56e-07 | 189 | 38 | 5 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | Endothelial-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 5.56e-07 | 189 | 38 | 5 | 04b565855f58ca0f343904d04be657b66e109076 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.56e-07 | 189 | 38 | 5 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.56e-07 | 189 | 38 | 5 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 5.71e-07 | 190 | 38 | 5 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-07 | 191 | 38 | 5 | 2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 191 | 38 | 5 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.86e-07 | 191 | 38 | 5 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.86e-07 | 191 | 38 | 5 | adb2e3efcad02889d8229325080da5e7830fd3ae | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.86e-07 | 191 | 38 | 5 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.86e-07 | 191 | 38 | 5 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-07 | 191 | 38 | 5 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.86e-07 | 191 | 38 | 5 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.86e-07 | 191 | 38 | 5 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-07 | 191 | 38 | 5 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.86e-07 | 191 | 38 | 5 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.86e-07 | 191 | 38 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-07 | 192 | 38 | 5 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-07 | 192 | 38 | 5 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.01e-07 | 192 | 38 | 5 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.01e-07 | 192 | 38 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.01e-07 | 192 | 38 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.01e-07 | 192 | 38 | 5 | 2802fae55683345ff94a1ecf73b6fbee4f17481e | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-07 | 192 | 38 | 5 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-07 | 192 | 38 | 5 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.01e-07 | 192 | 38 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.01e-07 | 192 | 38 | 5 | 011634a24b0c61d9b463fe755502edbc5cd70b7a | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-07 | 192 | 38 | 5 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.01e-07 | 192 | 38 | 5 | e79f2253e084a9ab9afcaf7ec42a5012ade42d36 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.17e-07 | 193 | 38 | 5 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-07 | 193 | 38 | 5 | 92048d2e9e43513e6185e09553be3ee47d7e5207 | |
| Computational | ECM and collagens. | 1.77e-04 | 225 | 26 | 5 | MODULE_47 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.28e-04 | 50 | 26 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Genes in the cancer module 236. | 8.41e-04 | 18 | 26 | 2 | MODULE_236 | |
| Computational | Neighborhood of CDH11 | 1.63e-03 | 25 | 26 | 2 | GNF2_CDH11 | |
| Computational | Ovary genes. | 1.66e-03 | 368 | 26 | 5 | MODULE_1 | |
| Computational | DRG (dorsal root ganglia) genes. | 2.00e-03 | 384 | 26 | 5 | MODULE_2 | |
| Computational | Genes in the cancer module 210. | 2.05e-03 | 28 | 26 | 2 | MODULE_210 | |
| Computational | Genes in the cancer module 46. | 2.24e-03 | 394 | 26 | 5 | MODULE_46 | |
| Computational | Immune response. | 2.35e-03 | 398 | 26 | 5 | MODULE_75 | |
| Drug | Cycloheximide [66-81-9]; Down 200; 14.2uM; HL60; HT_HG-U133A | 9.26e-06 | 171 | 38 | 5 | 2723_DN | |
| Drug | troglitazone; Down 200; 10uM; PC3; HG-U133A | 1.66e-05 | 193 | 38 | 5 | 462_DN | |
| Drug | genistein; Down 200; 10uM; HL60; HT_HG-U133A | 1.83e-05 | 197 | 38 | 5 | 2695_DN | |
| Drug | Propantheline bromide [50-34-0]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.97e-05 | 200 | 38 | 5 | 3352_UP | |
| Drug | SKF83742 | 4.05e-05 | 6 | 38 | 2 | CID000130828 | |
| Drug | C10A | 4.05e-05 | 6 | 38 | 2 | CID000041624 | |
| Drug | panobinostat | ADAMTS17 ADAMTS19 ASTN2 HHIP FRAS1 ERBB3 TMEM169 FBN1 WNT10B LRP8 | 4.78e-05 | 1333 | 38 | 10 | ctd:C496932 |
| Drug | Mustard Gas | 5.03e-05 | 1341 | 38 | 10 | ctd:D009151 | |
| Drug | Parathion | 5.21e-05 | 822 | 38 | 8 | ctd:D010278 | |
| Drug | AC1L1O6Q | 8.83e-05 | 141 | 38 | 4 | CID000058035 | |
| Drug | AC1NRB2N | 9.69e-05 | 9 | 38 | 2 | CID000445220 | |
| Drug | 3-nitrocoumarin | 1.21e-04 | 10 | 38 | 2 | CID002799766 | |
| Drug | isopetasin | 1.48e-04 | 11 | 38 | 2 | CID005318627 | |
| Drug | Fonofos | 1.57e-04 | 714 | 38 | 7 | ctd:D004397 | |
| Drug | Emetine dihydrochloride [316-42-7]; Down 200; 7.2uM; HL60; HT_HG-U133A | 1.62e-04 | 165 | 38 | 4 | 2145_DN | |
| Drug | terbufos | 1.71e-04 | 724 | 38 | 7 | ctd:C012568 | |
| Drug | AC1L1II7 | 1.77e-04 | 12 | 38 | 2 | CID000004589 | |
| Drug | fenoldopam | 2.17e-04 | 70 | 38 | 3 | CID000003340 | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 2.21e-04 | 179 | 38 | 4 | 5590_UP | |
| Drug | 1nmk | 2.27e-04 | 71 | 38 | 3 | CID000447401 | |
| Drug | 17alpha-estradiol | 2.31e-04 | 1303 | 38 | 9 | CID000000450 | |
| Drug | AC1MQNLW | 2.44e-04 | 14 | 38 | 2 | CID003504628 | |
| Drug | Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.56e-04 | 186 | 38 | 4 | 4163_UP | |
| Drug | Pimozide [2062-78-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.56e-04 | 186 | 38 | 4 | 3178_UP | |
| Drug | Androgen Antagonists | 2.67e-04 | 75 | 38 | 3 | ctd:D000726 | |
| Drug | WY-14643; Down 200; 100uM; PC3; HG-U133A | 2.89e-04 | 192 | 38 | 4 | 464_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.95e-04 | 193 | 38 | 4 | 4466_UP | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 4417_DN | |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 3507_UP | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; HL60; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 6178_DN | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 4422_DN | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 6247_UP | |
| Drug | AG-028671 [847803-03-6]; Up 200; 10uM; PC3; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 6557_UP | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; HL60; HG-U133A | 3.07e-04 | 195 | 38 | 4 | 1366_DN | |
| Drug | Cisapride [81098-60-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 3305_UP | |
| Drug | Propafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 2871_UP | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; HL60; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 2922_DN | |
| Drug | Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 3.13e-04 | 196 | 38 | 4 | 4415_DN | |
| Drug | Ketotifen fumarate [34580-14-8]; Up 200; 9.4uM; HL60; HG-U133A | 3.19e-04 | 197 | 38 | 4 | 1583_UP | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 5242_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 1183_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 10uM; PC3; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 4557_DN | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 4295_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 3357_UP | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 3940_UP | |
| Drug | m-3M3FBS | 3.21e-04 | 16 | 38 | 2 | CID000761523 | |
| Drug | gentamicin | 3.25e-04 | 198 | 38 | 4 | CID000003467 | |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 6742_DN | |
| Drug | Sulfisoxazole [127-69-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 3218_UP | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.25e-04 | 198 | 38 | 4 | 6786_UP | |
| Drug | Lansoprazole [103577-45-3]; Up 200; 10.8uM; PC3; HT_HG-U133A | 3.31e-04 | 199 | 38 | 4 | 7306_UP | |
| Drug | AC1L1GEZ | 3.38e-04 | 200 | 38 | 4 | CID000003653 | |
| Drug | Clidinium bromide [3485-62-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.38e-04 | 200 | 38 | 4 | 6837_UP | |
| Drug | Halofantrine hydrochloride [36167-63-2]; Up 200; 7.4uM; HL60; HT_HG-U133A | 3.38e-04 | 200 | 38 | 4 | 3130_UP | |
| Disease | dementia (is_implicated_in) | 3.96e-07 | 12 | 37 | 3 | DOID:1307 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome (implicated_via_orthology) | 4.59e-06 | 3 | 37 | 2 | DOID:0050475 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | TENM1 ADAMTS19 ASTN2 ERBB3 FN1 ABHD12B ADAMTS1 NOTCH4 WNT10B | 5.38e-06 | 1074 | 37 | 9 | C0006142 |
| Disease | Weill-Marchesani syndrome | 9.17e-06 | 4 | 37 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 9.17e-06 | 4 | 37 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | Common Migraine | 3.20e-05 | 7 | 37 | 2 | C0338480 | |
| Disease | aortic aneurysm | 6.84e-05 | 10 | 37 | 2 | EFO_0001666 | |
| Disease | FEV/FEC ratio | 1.16e-04 | 1228 | 37 | 8 | EFO_0004713 | |
| Disease | colorectal health | 1.16e-04 | 201 | 37 | 4 | EFO_0008460 | |
| Disease | migraine without aura, susceptibility to, 4 | 1.82e-04 | 16 | 37 | 2 | MONDO_0011847 | |
| Disease | Antimigraine preparation use measurement | 3.16e-04 | 21 | 37 | 2 | EFO_0009939 | |
| Disease | systemic scleroderma (is_implicated_in) | 4.15e-04 | 24 | 37 | 2 | DOID:418 (is_implicated_in) | |
| Disease | Mammary Carcinoma, Human | 4.77e-04 | 525 | 37 | 5 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 4.77e-04 | 525 | 37 | 5 | C1257931 | |
| Disease | Mammary Neoplasms | 4.85e-04 | 527 | 37 | 5 | C1458155 | |
| Disease | Breast Carcinoma | 5.32e-04 | 538 | 37 | 5 | C0678222 | |
| Disease | Alzheimer's disease (is_implicated_in) | 6.08e-04 | 132 | 37 | 3 | DOID:10652 (is_implicated_in) | |
| Disease | spontaneous coronary artery dissection | 6.95e-04 | 31 | 37 | 2 | EFO_0010820 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 7.07e-04 | 139 | 37 | 3 | DOID:3908 (is_implicated_in) | |
| Disease | Schizophrenia | 7.43e-04 | 883 | 37 | 6 | C0036341 | |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 7.88e-04 | 33 | 37 | 2 | EFO_0003761, EFO_0004952, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | brain volume measurement | 8.38e-04 | 595 | 37 | 5 | EFO_0006930 | |
| Disease | colorectal cancer | 8.96e-04 | 604 | 37 | 5 | MONDO_0005575 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 1.06e-03 | 160 | 37 | 3 | DOID:5844 (biomarker_via_orthology) | |
| Disease | dentate gyrus volume measurement | 1.10e-03 | 39 | 37 | 2 | EFO_0010083 | |
| Disease | body surface area | 1.18e-03 | 643 | 37 | 5 | EFO_0022196 | |
| Disease | Congenital small ears | 1.22e-03 | 41 | 37 | 2 | C0152423 | |
| Disease | hippocampal CA4 volume | 1.22e-03 | 41 | 37 | 2 | EFO_0009396 | |
| Disease | Nodular glomerulosclerosis | 1.22e-03 | 41 | 37 | 2 | C0017667 | |
| Disease | cortical surface area measurement | 1.25e-03 | 1345 | 37 | 7 | EFO_0010736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGKVCDPLCSSGGCW | 496 | P21860 | |
| RKPKCDCTESWGGCI | 446 | O75077 | |
| PSCRGEDAKGKDCCW | 116 | Q7Z5M8 | |
| GKCICQPDWTGKDCS | 696 | O75078 | |
| KCFCCDGGLRCWESG | 291 | Q13489 | |
| VDCGKGHLFCWECLG | 456 | Q9P2G1 | |
| CSGKGDVIDDWCRCD | 1036 | O75129 | |
| DGTECGVEKWCSKGR | 356 | Q76LX8 | |
| CGADKWCRAGECVSK | 521 | Q8TE56 | |
| GTDCDLGKWCKAGEC | 611 | Q8TE59 | |
| EAGVWSECSVKCGKG | 1041 | Q8TE59 | |
| GTSCGEGKWCINGKC | 531 | Q9UHI8 | |
| AGCEGGCCCWDVRLD | 461 | Q9UFC0 | |
| GEKWEDGPCKVCECR | 371 | Q86XX4 | |
| CKLHFWVCDGEDDCG | 3686 | Q9NZR2 | |
| CISKQWLCDGSDDCG | 2746 | Q07954 | |
| CKPLAWKCDGEDDCG | 3666 | Q07954 | |
| AEWEAACVKAGRKCG | 391 | Q8NDH3 | |
| DLSCAWEGCMKGGLC | 111 | Q8N7R1 | |
| ECVCLGNGKGEWTCK | 166 | P02751 | |
| QECCCALKGEGWGDP | 2081 | P35555 | |
| FCLCKAGWGGRLCDK | 141 | Q14393 | |
| KACGACPLWGKCDAE | 771 | P10643 | |
| VDCEEGWALAKCGGK | 141 | Q5T764 | |
| IDCEEGWALLKCGGK | 141 | P09914 | |
| DCGKCKCDQGWYGDA | 111 | O95965 | |
| GKCGCPWCALNGKAE | 66 | Q8TDX9 | |
| SEGGDCKEPDKCCWR | 56 | Q8NCQ7 | |
| GWRCDGDRDCKDKSD | 276 | Q14114 | |
| CACPEGWAGLACEKE | 1061 | O75095 | |
| LAGCRCVELDCWDGK | 351 | Q15147 | |
| CKDGKCECSPGWEGD | 736 | Q9UKZ4 | |
| GHCEKGCNTAECGWD | 1266 | Q99466 | |
| GKCCCSPGWEGDFCR | 621 | Q96QV1 | |
| GCECGDKGKCSDSSL | 16 | Q9NYP9 | |
| SGCRCVELDCWKGKP | 351 | Q00722 | |
| CSLGKLVSCGCGWKG | 136 | O00744 | |
| GFCGWLCSKLGLEDC | 251 | Q96HH4 | |
| EKGWECGDCGKVFRG | 126 | Q9NSD4 | |
| CGSGECIHKKWRCDG | 246 | P98155 |